After yesterday's big plunge in the stock market, and today with the Dow Jones Industrial Average dropping more than 500 points after opening, but mostly recovering, volatility appears to be…

Genentech said the Phase III combination therapy improved progression-free survival by 26 percent in mRCC patients whose disease expressed a PD-L1 protein. Source: BioSpace

The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace

The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas. Source: BioSpace

Zogenix’s first global Phase 3 trial of ZX008, met the primary efficacy endpoint, as well as all prespecified key secondary efficacy endpoints. Source: BioSpace

According to sources reported by Reuters, potential buyers have been winnowed down to two pharma companies, three private equity funds, and a consortium of buyers. Source: BioSpace

The international clinical study, OPTIMISMM, achieved its primary endpoint. Source: BioSpace

The company says the vaccine takes a novel approach. Source: BioSpace

He will be based out of MannKind’s Westlake Village, California headquarters. Source: BioSpace

Visterra has outgrown its headquarters and is moving to a site double the size in suburban Waltham, MA. Source: BioSpace